Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.7M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$183M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Reardon Andrew | Sep 23, 2024 | Sell | 2,000 | $99.6005 | $200,000 |
| Korenberg Matthew E | Sep 23, 2024 | Sell | 7,090 | $101.605 | $720,000 |
| Korenberg Matthew E | Sep 23, 2024 | Sell | 2,481 | $100.0517 | $250,000 |
| Korenberg Matthew E | Sep 23, 2024 | Sell | 201 | $102.0541 | $21,000 |
| Korenberg Matthew E | Sep 20, 2024 | Sell | 6,275 | $104.1017 | $650,000 |
| Espinoza Octavio | Sep 20, 2024 | Sell | 800 | $103.95 | $83,000 |
| Espinoza Octavio | Sep 20, 2024 | Sell | 275 | $103.8625 | $29,000 |
| Espinoza Octavio | Sep 20, 2024 | Sell | 200 | $103.98 | $21,000 |
| Reardon Andrew | Aug 28, 2024 | Sell | 1,500 | $106.3937 | $160,000 |
| Korenberg Matthew E | Aug 26, 2024 | Sell | 6,177 | $105.016 | $650,000 |
| Korenberg Matthew E | Aug 26, 2024 | Sell | 5,212 | $106.3214 | $550,000 |
| Korenberg Matthew E | Aug 23, 2024 | Sell | 4,275 | $105.1319 | $450,000 |
| Korenberg Matthew E | Aug 23, 2024 | Sell | 2,037 | $104.0945 | $210,000 |
| Korenberg Matthew E | Aug 22, 2024 | Sell | 1,157 | $105.54 | $120,000 |
| Korenberg Matthew E | Aug 9, 2024 | Sell | 18,245 | $98.5 | $1.8M |
| Davis Todd C | Aug 8, 2024 | Buy | 2,500 | $97.3922 | $240,000 |
| Espinoza Octavio | May 17, 2024 | Sell | 5,022 | $86.6652 | $440,000 |
| Espinoza Octavio | May 17, 2024 | Sell | 134 | $86.6497 | $12,000 |
| Espinoza Octavio | May 16, 2024 | Sell | 2,264 | $86.0034 | $190,000 |
| Espinoza Octavio | May 15, 2024 | Sell | 5,873 | $86.012 | $510,000 |
| Korenberg Matthew E | May 14, 2024 | Sell | 13,638 | $85.0826 | $1.2M |
| Korenberg Matthew E | May 14, 2024 | Sell | 520 | $85.6841 | $45,000 |
| Korenberg Matthew E | May 13, 2024 | Sell | 3,440 | $84.5431 | $290,000 |
| Reardon Andrew | May 9, 2024 | Sell | 10,000 | $83.0449 | $830,000 |
| Gray Nancy Ryan | May 9, 2024 | Sell | 934 | $83.2049 | $78,000 |
| Sabba Stephen L | Mar 5, 2024 | Sell | 1,893 | $74.3 | $140,000 |
| Espinoza Octavio | Feb 28, 2024 | Sell | 140 | $88.46 | $12,000 |
| Davis Todd C | Sep 22, 2023 | Buy | 4,000 | $59.3822 | $240,000 |
| KOZARICH JOHN W | May 16, 2023 | Sell | 4,444 | $77.2009 | $340,000 |
| Sabba Stephen L | May 10, 2023 | Sell | 6,408 | $77.1262 | $490,000 |
| KOZARICH JOHN W | May 8, 2023 | Sell | 5,819 | $76.511 | $450,000 |
| KOZARICH JOHN W | May 8, 2023 | Sell | 589 | $77.0974 | $45,000 |
| Reardon Andrew | Mar 24, 2023 | Sell | 300 | $69.9243 | $21,000 |
| HIGGINS JOHN L | Dec 16, 2022 | Sell | 10,000 | $61.8657 | $620,000 |
What's the latest insider transaction for Ligand Pharmaceuticals?
The most recent insider transaction for Ligand Pharmaceuticals was conducted by Reardon Andrew, who sold 2,000 shares on September 23, 2024 at a price of $99.60 per share.
Which insider bought the most LGND stock over the last two years?
Davis Todd C has bought the most LGND stock in the last 2 years, with a total value of $480,000.
Which insider has sold the most LGND stock over the last two years?
Korenberg Matthew E has sold the most LGND stock in the last 2 years, with a total value of $6.9M.
What is the total value of insider transactions for Ligand Pharmaceuticals (LGND) in the last 2 years?
The total value of insider transactions for Ligand Pharmaceuticals in the last 2 years is negative, amounting to -$11M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Ligand Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Ligand Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
